[go: up one dir, main page]

CN104013669A - Method for preparing cyclocarya paliurus total flavonoid with effect of reducing blood glucose - Google Patents

Method for preparing cyclocarya paliurus total flavonoid with effect of reducing blood glucose Download PDF

Info

Publication number
CN104013669A
CN104013669A CN201410293019.XA CN201410293019A CN104013669A CN 104013669 A CN104013669 A CN 104013669A CN 201410293019 A CN201410293019 A CN 201410293019A CN 104013669 A CN104013669 A CN 104013669A
Authority
CN
China
Prior art keywords
ethanol
cyclocarya paliurus
total flavonoids
preparation
polyamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410293019.XA
Other languages
Chinese (zh)
Inventor
梁侨丽
刘杰
邹娜姝
李军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing University of Chinese Medicine
Original Assignee
Nanjing University of Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing University of Chinese Medicine filed Critical Nanjing University of Chinese Medicine
Priority to CN201410293019.XA priority Critical patent/CN104013669A/en
Publication of CN104013669A publication Critical patent/CN104013669A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明涉及从青钱柳叶中得到具有降血糖作用的总黄酮的制备方法。取青钱柳干燥叶,加入8~12倍量70~85%的乙醇水溶液,然后回流提取3次,每次2h,滤过,合并提取液,浓缩。取浓缩后的干浸膏加75%乙醇溶解,与30~60目的聚酰胺,按1∶1~3拌样,按1∶10~15上柱,再分别用水、40%乙醇、45~60%乙醇、80~90%乙醇洗脱;且各梯度均洗脱10个柱体积,其中45~60%乙醇部位分两段,即45~60%乙醇上(前5个柱体积)和45~60%乙醇下(后5个柱体积);45~60%乙醇下部分和80~90%乙醇部分合并即为总黄酮,且含量达到50%以上。经药理实验表明,青钱柳总黄酮具有良好的降血糖作用。The invention relates to a preparation method for obtaining total flavonoids with hypoglycemic effect from leaves of Cyclocarya paliurus. Take the dry leaves of Cyclocarya paliurana, add 8-12 times the amount of 70-85% ethanol aqueous solution, then reflux extraction for 3 times, each time for 2 hours, filter, combine the extracts, and concentrate. Take the concentrated dry extract and dissolve it in 75% ethanol, mix the sample with 30-60 mesh polyamide according to 1:1-3, put it on the column according to 1:10-15, and then use water, 40% ethanol, 45-60 % ethanol, 80-90% ethanol; and each gradient is eluted for 10 column volumes, of which 45-60% ethanol is divided into two sections, that is, 45-60% ethanol (the first 5 column volumes) and 45-60% ethanol Under 60% ethanol (the last 5 column volumes); the part under 45-60% ethanol and the part under 80-90% ethanol are combined to form the total flavonoids, and the content reaches more than 50%. Pharmacological experiments show that the total flavonoids of Cyclocarya paliurus has a good hypoglycemic effect.

Description

具有降血糖作用的青钱柳总黄酮的制备方法Preparation method of total flavonoids of Cyclocarya paliurus with hypoglycemic effect

技术领域technical field

本发明涉及从青钱柳叶中得到具有降血糖作用的总黄酮制备方法。The invention relates to a preparation method for obtaining total flavonoids with hypoglycemic effect from Cyclocarya paliurus leaves.

背景技术Background technique

糖尿病是一种因胰岛素分泌相对或绝对不足以及靶组织细胞对胰岛素敏感性降低,引起糖、蛋白、脂肪、水和电解质代谢紊乱,是常见的多发性慢性疾病。与癌症、心血管疾病并称为世界三大疾病,最大特点是病程长且复杂、难根治。临床分为胰岛素依赖型(1型)和非胰岛素依赖型(2型)两类,其中2型糖尿病占90%~95%。2型糖尿病,必须严格控制血糖水平及相关的危险因素才能改善患者的生存质量。目前全世界约有3.6亿糖尿病患者,而在1985年,全世界糖尿病患者只有3000万,2000年增加到1.5亿,预计到2030年将直奔6亿。随着经济的快速发展、生活方式的改变和人口寿命的延长,中国糖尿病患病率增长迅速。目前我国20岁以上的成人糖尿病患病率已经超过10%,另有16%处于糖尿病边缘,预计每天新增加的糖尿病患者约为3000例。我国目前已有糖尿病患者人数约9400万,已取代印度,成为世界上糖尿病人数最多的国家。高血糖是糖尿病的主要标志,高血糖可引起微血管病变,使糖尿病患者的微循环有不同程度的异常。随着病程的延长和治疗不及时会促使微血管病变的加重和发展,引起全身各种急、慢性并发症,累及多个器官和组织,导致失明、肾功能衰竭、心血管疾病、神经病变、肢体坏疽等,甚至死亡。糖尿病已成为继心血管病、恶性肿瘤之后致人类死亡的第三大“健康杀手”,目前全世界每年有400万人死于糖尿病或糖尿病并发症。必须严格控制糖尿病的血糖水平及相关的危险因素才能改善患者的生存质量。Diabetes mellitus is a common multiple chronic disease caused by relative or absolute deficiency of insulin secretion and decreased sensitivity of target tissue cells to insulin, resulting in disturbance of sugar, protein, fat, water and electrolyte metabolism. Together with cancer and cardiovascular disease, it is called the world's three major diseases. The biggest feature is that the course of the disease is long and complicated, and it is difficult to cure. Clinically divided into two types: insulin-dependent (type 1) and non-insulin-dependent (type 2), of which type 2 diabetes accounts for 90% to 95%. Type 2 diabetes must strictly control blood sugar levels and related risk factors in order to improve the quality of life of patients. At present, there are about 360 million diabetic patients in the world. In 1985, there were only 30 million diabetic patients in the world. In 2000, the number increased to 150 million. It is estimated that by 2030, it will go straight to 600 million. With the rapid economic development, changes in lifestyle and prolongation of life expectancy, the prevalence of diabetes in China has increased rapidly. At present, the prevalence of diabetes in adults over the age of 20 in my country has exceeded 10%, and another 16% are on the verge of diabetes. It is estimated that about 3,000 new diabetic patients will be added every day. At present, my country has about 94 million diabetic patients, and has replaced India as the country with the largest number of diabetics in the world. Hyperglycemia is the main sign of diabetes. Hyperglycemia can cause microangiopathy and make the microcirculation of diabetic patients abnormal in varying degrees. With the prolongation of the disease course and untimely treatment, the aggravation and development of microvascular disease will be promoted, causing various acute and chronic complications throughout the body, involving multiple organs and tissues, leading to blindness, renal failure, cardiovascular disease, neuropathy, limb gangrene, etc., and even death. Diabetes has become the third "health killer" that causes human death after cardiovascular disease and malignant tumors. At present, 4 million people in the world die of diabetes or complications of diabetes every year. Diabetic blood sugar levels and related risk factors must be strictly controlled in order to improve the quality of life of patients.

青钱柳(Cyclocarya paliurus(Batal)Ijinskaja)又称摇钱树、麻柳系双子叶植物纲胡桃科青钱柳属植物,是中国特有的国家二级保护树种和国家重点保护的濒危植物品种,广泛分布于江西、广西、四川、贵州、湖北等十三个省区(中国科学院中国植物志编辑委员会.中国植物志[M].第21卷.北京:科学出版社,1979:118-1911)。青钱柳具有丰富的生物活性成分和较高的医疗价值,其树叶、树皮、树根可入药,性温,味辛微苦,具有清热消肿、解毒、止痛功能(中国药材公司.中国中药资源志要[M].北京:科学出版社,1994);现代药理学表明,青钱柳提取物具有降血糖、降血压、降血脂等生理活性,同时还有增强肌体免疫力、抗氧化、抗癌等生理功能,其在防治糖尿病方面功效尤为突出(王克全,曹莹.青钱柳化学成分及药理作用的研究进展[J].黑龙江医学.2007,8(31):577-579)。动物实验和临床研究发现,青钱柳叶及其提取物或有效部位都有明显降血糖作用,能有效降低小鼠餐后血糖,提高小鼠糖耐量,降低高糖高脂所致糖尿病小鼠血糖、胆固醇和甘油三酯含量,且能改善胰岛素抵抗。Cyclocarya paliurus (Batal) Ijinskaja, also known as money tree and willow, is a plant of the genus Juglandaceae Cyclocarya paliurus (Batal) Ijinskaja. It is a unique national second-class protected tree species and an endangered plant species under national key protection. In thirteen provinces including Jiangxi, Guangxi, Sichuan, Guizhou, Hubei, etc. Cyclocarya paliurus has rich bioactive ingredients and high medical value. Its leaves, bark, and roots can be used as medicine. It is warm in nature, pungent and slightly bitter, and has the functions of clearing away heat, reducing swelling, detoxifying, and relieving pain (China Medicinal Materials Corporation. China Summary of Chinese Medicine Resources [M]. Beijing: Science Press, 1994); modern pharmacology shows that Cyclocarya paliurus extract has physiological activities such as lowering blood sugar, lowering blood pressure, and lowering blood fat. , anti-cancer and other physiological functions, especially in the prevention and treatment of diabetes (Wang Kequan, Cao Ying. Research progress on chemical constituents and pharmacological effects of Cyclocarya paliurus [J]. Heilongjiang Medicine. 2007, 8(31): 577-579) . Animal experiments and clinical studies have found that Cyclocarya paliurus leaves and their extracts or effective parts have obvious hypoglycemic effects, can effectively reduce postprandial blood sugar in mice, improve glucose tolerance in mice, and reduce the risk of diabetes in mice caused by high sugar and high fat. Blood sugar, cholesterol and triglyceride levels, and can improve insulin resistance.

发明内容Contents of the invention

本发明的目的是提供一种具有降血糖作用的青钱柳总黄酮的制备方法;本发明的制备方法工艺操作简单,能够提供性能稳定、药理活性好的青钱柳总黄酮。The purpose of the present invention is to provide a preparation method of total flavonoids of Cyclocarya paliurus with hypoglycemic effect; the preparation method of the present invention is simple in process and operation, and can provide total flavonoids of Cyclocarya paliurus with stable performance and good pharmacological activity.

具有降血糖作用的青钱柳总黄酮的制备方法,包括以下步骤:The preparation method of total flavonoids of Cyclocarya paliurus with hypoglycemic effect comprises the following steps:

(1)提取:取青钱柳的干燥叶,用乙醇水溶液浸泡,提取,得到提取液,浓缩得干浸膏(1) Extraction: take the dried leaves of Cyclocarya paliurus, soak them in aqueous ethanol solution, extract, obtain the extract, concentrate to obtain dry extract

(2)聚酰胺柱层析:将步骤(1)得到的浸膏,加乙醇溶解,与聚酰胺拌样后上聚酰胺柱,再分别用不同梯度的乙醇溶液进行洗脱,得到洗脱液,浓缩,挥干溶剂得青钱柳总黄酮。(2) Polyamide column chromatography: Dissolve the extract obtained in step (1) with ethanol, mix it with polyamide, put it on a polyamide column, and then elute with ethanol solutions of different gradients to obtain eluent , concentrated, and the solvent was evaporated to obtain the total flavonoids of Cyclocarya paliurus.

上述步骤(1)所用的乙醇水溶液浓度为70~85%,每次加入相当于药材重量的8~12倍重量的提取溶剂,加热回流提取,每次提取保持微沸状态2h,提取3次。The concentration of the aqueous ethanol solution used in the above step (1) is 70-85%, adding an extraction solvent equivalent to 8-12 times the weight of the medicinal material each time, heating and refluxing for extraction, keeping a slight boiling state for 2 hours each time, and extracting 3 times.

上述步骤(2)中聚酰胺为30~60目,拌样所用乙醇浓度为75%,浸膏与聚酰胺按1∶1~3拌样,按1∶10~15上柱。In the above step (2), the polyamide is 30-60 mesh, the ethanol concentration used for mixing the sample is 75%, the extract and the polyamide are mixed at a ratio of 1:1-3, and the column is loaded at a ratio of 1:10-15.

上述步骤(2)所述的不同梯度的乙醇溶液分别为水、40%乙醇、45~60%乙醇、80~90%乙醇;且各梯度均洗脱10个柱体积,其中45~60%乙醇部位分两段,即45~60%乙醇上(前5个柱体积)和45~60%乙醇下(后5个柱体积);45~60%乙醇下部分和80~90%乙醇部分合并即为总黄酮,且含量达到50%以上。The ethanol solutions of different gradients described in the above step (2) are water, 40% ethanol, 45-60% ethanol, 80-90% ethanol respectively; The part is divided into two sections, that is, the upper part of 45-60% ethanol (the first 5 column volumes) and the lower part of 45-60% ethanol (the last 5 column volumes); the lower part of 45-60% ethanol and the part of 80-90% ethanol are combined It is the total flavonoids, and the content reaches more than 50%.

本发明中的青钱柳总黄酮含量达到了50%以上,可制成药剂学上任何可接受的制剂,例如制成口服给药制剂:片剂、丸剂、胶囊剂、颗粒剂、滴丸剂、口服液等。The total flavonoid content of Cyclocarya paliurus in the present invention has reached more than 50%, and can be made into any pharmaceutically acceptable preparations, such as oral administration preparations: tablets, pills, capsules, granules, dropping pills, Oral liquid, etc.

本发明所述的制备方法制备的青钱柳总黄酮,以阿卡波糖为对照,设置不同浓度组进行了体外α-葡萄糖苷酶活性抑制实验,结果表明青钱柳总黄酮对α-葡萄糖苷酶具有很强的抑制作用;阿卡波糖和青钱柳总黄酮的IC50值分别为58.608mg/L和45.691mg/L。The total flavonoids of Cyclocarya paliurus prepared by the preparation method of the present invention, with acarbose as a contrast, set different concentration groups and carried out the in vitro α-glucosidase activity inhibition experiment, the results show that the total flavonoids of Cyclocarya paliurus has an effect on α-glucose Glucosidase has a strong inhibitory effect; the IC50 values of acarbose and total flavonoids of Cyclocarya paliurus are 58.608mg/L and 45.691mg/L, respectively.

本发明所述的制备方法制备的青钱柳总黄酮在降低小鼠血糖的实验(糖耐量实验)研究中,40只小鼠分成5组,每组8只,分别为空白组、蔗糖组、蔗糖+总黄酮组、淀粉组、淀粉+总黄酮组,以各组小鼠血糖浓度为指标,以眼眶取血方式取灌胃后1h和2h小鼠血浆测定血糖浓度,结果表明青钱柳总黄酮具有良好的降血糖作用。The total flavonoids of Cyclocarya paliurus prepared by the preparation method of the present invention is in the experiment (glucose tolerance test) research of lowering the blood sugar of mice, 40 mice are divided into 5 groups, 8 in every group, respectively blank group, sucrose group, Sucrose + total flavonoids group, starch group, starch + total flavonoids group, taking the blood glucose concentration of the mice in each group as an index, taking blood from the orbit to measure the blood glucose concentration of the mice 1h and 2h after gavage, the results showed that the total Flavonoids have a good hypoglycemic effect.

本发明中青钱柳总黄酮的制备步骤少,操作简便,成本低,总黄酮含量高;并且青钱柳总黄酮对α-葡萄糖苷酶具有很强的抑制作用,能有效的降血糖,可用于制备预防和治疗糖尿病的药物,为进一步开发利用青钱柳的要用价值指明了方向。The preparation steps of the total flavonoids of Cyclocarya paliurus in the present invention are less, the operation is simple, the cost is low, and the content of total flavonoids is high; and the total flavonoids of Cyclocarya paliurus has a strong inhibitory effect on α-glucosidase, can effectively lower blood sugar, and can be used It is suitable for the preparation of drugs for the prevention and treatment of diabetes, and points out the direction for the further development and utilization of the useful value of Cyclocarya paliurus.

附图说明Description of drawings

淀粉、蔗糖糖耐量实验结果。Starch and sucrose glucose tolerance test results.

具体实施方式Detailed ways

以下通过具体实施例对本发明的内容作进一步详细的说明,但这些实施例绝不应该被理解为对本发明的限制。本领域的技术人员在不脱离本发明上述思想情况下,对本发明实施所做的任何变动,均包含在本发明之内。The content of the present invention will be further described in detail below through specific examples, but these examples should never be construed as limiting the present invention. Any changes made to the implementation of the present invention by those skilled in the art without departing from the above-mentioned idea of the present invention are included in the present invention.

实施例1青钱柳总黄酮的制备The preparation of embodiment 1 Cyclocarya paliurus total flavonoids

(1)提取:称取青钱柳干燥粗叶0.8Kg,用75%乙醇回流提取3次,每次2h,每次乙醇用量8000ml。合并提取液并回收乙醇得乙醇提取物干浸膏。(1) Extraction: Weigh 0.8Kg of dried and thick leaves of Cyclocarya paliurus, and reflux extract with 75% ethanol for 3 times, each time for 2 hours, and the amount of ethanol is 8000ml each time. Combine the extracts and recover ethanol to obtain dry extract of ethanol extract.

(2)聚酰胺柱层析:称取已处理好的聚酰胺125g(30-60目),湿法装柱(柱5cm×70cm),柱体积(BV)750ml。再称取醇提物干浸膏10.0g,用75%乙醇溶解,拌入已处理好的聚酰胺20g中,挥干乙醇,装入柱中。分别用水、40%乙醇、50%乙醇上(前5个柱体积)、50%7醇下(后5个柱体积)、80%乙醇,每个梯度洗脱10BV。将50%乙醇下和80%乙醇部分合并,用硝酸铝显色法测定总黄酮含量为55.66%。(2) Polyamide column chromatography: Weigh 125 g (30-60 mesh) of the treated polyamide, and wet-pack it into a column (column 5 cm×70 cm), with a column volume (BV) of 750 ml. Then weigh 10.0 g of the dry extract of the ethanol extract, dissolve it with 75% ethanol, mix it into 20 g of the treated polyamide, evaporate the ethanol to dryness, and put it into the column. Each gradient eluted 10BV with water, 40% ethanol, 50% ethanol (first 5 column volumes), 50% alcohol (last 5 column volumes), 80% ethanol, respectively. The 50% ethanol and 80% ethanol parts were combined, and the total flavonoid content was determined to be 55.66% by the aluminum nitrate color method.

实施例2青钱柳总黄酮对α-葡萄糖苷酶活性的抑制作用Example 2 Inhibitory effect of total flavonoids of Cyclocarya paliurus on α-glucosidase activity

青钱柳总黄酮对α-葡萄糖苷酶活性的抑制作用实验分为空白组、阿卡波糖不同浓度组(终浓度分别为250mg/L、125mg/L、62.50mg/L、31.25mg/L、15.63mg/L、7.81mg/L、7.81mg/L、0mg/L)和总黄酮不同浓度组(终浓度分别为250mg/L、125mg/L、62.50mg/L、31.25mg/L、15.63mg/L、7.81mg/L、7.81mg/L、0mg/L)。操作过程式是在试管中分别加入磷酸盐缓冲液2mL、NPG(4-硝基苯酚-α-D吡喃葡萄糖苷)溶液0.2mL、阿卡波糖或青钱柳总黄酮溶液0.1mL,空白组加入PBS0.3mL,于37℃恒温水浴10min;再加入α-葡萄糖苷酶溶液0.2mL(空白组不添加),于37℃恒温水浴10min,加入乙醇1.5mL终止反应,用岛津U V-120-02紫外可见分光光度计在405nm处测定吸光值。酶活性抑制率公式如下:The inhibitory effect of total flavonoids of Cyclocarya paliurus on α-glucosidase activity was divided into blank group and different concentration groups of acarbose (final concentrations were 250mg/L, 125mg/L, 62.50mg/L, 31.25mg/L, respectively). , 15.63mg/L, 7.81mg/L, 7.81mg/L, 0mg/L) and different concentration groups of total flavonoids (final concentrations were 250mg/L, 125mg/L, 62.50mg/L, 31.25mg/L, 15.63 mg/L, 7.81mg/L, 7.81mg/L, 0mg/L). The operation procedure is to add 2 mL of phosphate buffer, 0.2 mL of NPG (4-nitrophenol-α-D glucopyranoside) solution, 0.1 mL of acarbose or total flavonoids of Cyclocarya paliurus into the test tube, and blank Add PBS0.3mL to the group, and put it in a constant temperature water bath at 37°C for 10min; then add 0.2mL of α-glucosidase solution (no addition in the blank group), put it in a constant temperature water bath at 37°C for 10min, add 1.5mL of ethanol to terminate the reaction, and use Shimadzu U V- 120-02 UV-Vis spectrophotometer to measure the absorbance at 405nm. The enzyme activity inhibition rate formula is as follows:

(A阴性对照:即各部位含量为0mg/L时的吸光度)(A negative control : the absorbance when the content of each part is 0mg/L)

附表1青钱柳总黄酮对α-葡萄糖苷酶活性的抑制作用实验结果Attached table 1 Experimental results of the inhibitory effect of total flavonoids of Cyclocarya paliurus on α-glucosidase activity

阿卡波糖和青钱柳总黄酮的IC50值分别为58.608mg/L和45.691mg/L。实验数据以SPSS17.0软件进行处理。The IC 50 values of acarbose and total flavonoids of Cyclocarya paliurus were 58.608mg/L and 45.691mg/L, respectively. The experimental data were processed with SPSS17.0 software.

实施例3青钱柳总黄酮糖耐量实验Example 3 Glucose tolerance test of total flavonoids of Cyclocarya paliurus

实验动物:ICR雄性小鼠,购自南京青龙山实验动物中心,体重范围:18~22g。Experimental animals: ICR male mice, purchased from Nanjing Qinglongshan Experimental Animal Center, weight range: 18-22 g.

实验方法experimental method

ICR雄性小鼠适应性饲养2-3d,随机分为空白组、蔗糖组、蔗糖+总黄酮组、淀粉组、淀粉+总黄酮组,每组8只,实验前,小鼠空腹20h。空白组:灌胃1ml生理盐水;蔗糖组:灌胃1ml蔗糖溶液(用生理盐水按3g/Kg剂量配制);蔗糖+总黄酮组:同时灌胃0.5ml蔗糖溶液(用生理盐水按3g/Kg剂量配制)和0.5ml总黄酮(用生理盐水按600mg/Kg剂量配制);淀粉组:灌胃1ml淀粉溶液(用生理盐水按3g/Kg剂量配制);淀粉+总黄酮组:同时灌胃0.5ml淀粉溶液(用生理盐水按3g/Kg剂量配制)和0.5ml80%乙醇部位(用生理盐水按600mg/Kg剂量配制)。各组动物灌胃后0、1、2h眼眶取血,用葡萄糖氧化酶法试剂盒测量各时间点的血糖值。实验结果见附表2。ICR male mice were adaptively fed for 2-3 days, and randomly divided into blank group, sucrose group, sucrose+total flavonoids group, starch group, starch+total flavonoids group, with 8 mice in each group. Before the experiment, the mice were fasted for 20 hours. Blank group: gavage 1ml of normal saline; sucrose group: gavage of 1ml sucrose solution (prepared with normal saline at a dose of 3g/Kg); sucrose+total flavonoids group: gavage of 0.5ml sucrose solution dosage preparation) and 0.5ml total flavonoids (prepared by 600mg/Kg dose with normal saline); starch group: gavage 1ml starch solution (prepared by 3g/Kg dose with normal saline); ml starch solution (prepared by 3g/Kg dosage with physiological saline) and 0.5ml 80% ethanol part (prepared by 600mg/Kg dosage with physiological saline). Blood was collected from the orbits of the animals in each group at 0, 1, and 2 hours after gavage, and the blood glucose values at each time point were measured with a glucose oxidase method kit. The experimental results are shown in Table 2.

附表2总黄酮糖耐量实验结果Attached Table 2 Total Flavonoids Glucose Tolerance Test Results

实验数据以以SPSS17.0软件进行统计分析,结果以Mean±SD表示,“p#<0.001”表示空白组与模型组之间存在显著性差异;“p**<0.01,p***<0.001”,表示模型组与给药组之间存在显著性差异。The experimental data was statistically analyzed with SPSS17.0 software, and the results were expressed as Mean±SD, "p#<0.001" indicated that there was a significant difference between the blank group and the model group; "p**<0.01, p***< 0.001", indicating that there is a significant difference between the model group and the treatment group.

总黄酮和蔗糖、淀粉混合给小鼠灌胃,1h、2h后的血糖值均低于蔗糖、淀粉单独灌胃后1h、2h的血糖值,差异有显著性(p<0.01)意义,说明总黄酮对降低小鼠血糖具有很好的效果。The total flavonoids mixed with sucrose and starch were administered to mice, and the blood glucose values after 1h and 2h were lower than those of 1h and 2h after sucrose and starch were administered alone, and the difference was significant (p<0.01), indicating that the total Flavonoids have a good effect on reducing blood sugar in mice.

Claims (8)

1.具有降血糖作用的青钱柳总黄酮的制备方法,包括以下步骤:1. The preparation method of total flavonoids of Cyclocarya paliurus with hypoglycemic effect, comprising the following steps: (1)提取:取青钱柳的干燥叶,用乙醇水溶液浸泡,提取,得到提取液,浓缩得干浸膏;(1) Extraction: get the dried leaves of Cyclocarya paliurus, soak with ethanol aqueous solution, extract, obtain extract, concentrate to obtain dry extract; (2)聚酰胺柱层析:将步骤(1)得到的浸膏,加乙醇溶解,与聚酰胺拌样后上聚酰胺柱,再分别用不同梯度的乙醇溶液进行洗脱,得到洗脱液,浓缩,挥干溶剂得青钱柳总黄酮。(2) Polyamide column chromatography: Dissolve the extract obtained in step (1) with ethanol, mix it with polyamide, put it on a polyamide column, and then elute with ethanol solutions of different gradients to obtain eluent , concentrated, and the solvent was evaporated to obtain the total flavonoids of Cyclocarya paliurus. 2.根据权利要求1所述的青钱柳总黄酮的制备方法,其特征在于,步骤(1)中,所用的乙醇水溶液浓度为70~85%。2. The preparation method of total flavonoids of Cyclocarya paliurus according to claim 1, characterized in that, in step (1), the concentration of the aqueous ethanol solution used is 70-85%. 3.根据权利要求1所述的青钱柳总黄酮的制备方法,其特征在于,步骤(1)中,每次加入相当于药材重量的8~12倍重量的提取溶剂,加热回流提取,每次提取保持微沸状态2h,提取3次。3. the preparation method of Cyclocarya paliurus total flavonoids according to claim 1, is characterized in that, in step (1), add the extraction solvent that is equivalent to 8~12 times weight of medical material weight at every turn, heat reflux extraction, every time The second extraction was kept in a slightly boiling state for 2 hours, and extracted 3 times. 4.根据权利要求1所述的青钱柳总黄酮的制备方法,其特征在于,步骤(2)中,聚酰胺为30~60目,拌样所用乙醇浓度为75%,浸膏与聚酰胺按1∶1~3拌样,按1∶10~15上柱。4. the preparation method of Cyclocarya paliurus total flavonoids according to claim 1, is characterized in that, in step (2), polyamide is 30~60 orders, and the used ethanol concentration of mixing sample is 75%, and extract and polyamide Mix the sample according to 1:1~3, and load the column according to 1:10~15. 5.根据权利要求1所述的青钱柳总黄酮的制备方法,其特征在于,步骤(2)中,所述的不同梯度的乙醇溶液分别为水、40%乙醇、45~60%乙醇、80~90%乙醇。5. the preparation method of Cyclocarya paliurus total flavonoids according to claim 1 is characterized in that, in step (2), the ethanol solutions of described different gradients are respectively water, 40% ethanol, 45~60% ethanol, 80-90% ethanol. 6.根据权利要求1所述的青钱柳总黄酮的制备方法,其特征在于,步骤(2)中所述的不同梯度的乙醇溶液均洗脱10个柱体积,其中45~60%乙醇部位分两段,即45~60%乙醇上(前5个柱体积)和45~60%乙醇下(后5个柱体积)。6. The preparation method of total flavonoids of Cyclocarya paliurus according to claim 1, is characterized in that, the ethanol solutions of different gradients described in step (2) all elute 10 column volumes, wherein 45~60% ethanol parts Divided into two sections, that is, above 45-60% ethanol (the first 5 column volumes) and under 45-60% ethanol (the last 5 column volumes). 7.根据权利要求1所述的青钱柳总黄酮的制备方法,其特征在于,步骤(2)中45~60%乙醇下部分和80~90%乙醇部分合并即为总黄酮,且含量达到50%以上。7. the preparation method of Cyclocarya paliurus total flavonoids according to claim 1, is characterized in that, in step (2), 45~60% ethanol lower part and 80~90% ethanol part merge and are total flavonoids, and content reaches above 50. 8.根据权利要求1~7项所述的制备方法制备青钱柳总黄酮在制备降血糖药物或者保健品中的应用。8. The application of total flavonoids of Cyclocarya paliurus in the preparation of hypoglycemic drugs or health care products according to the preparation method described in claims 1-7.
CN201410293019.XA 2014-06-24 2014-06-24 Method for preparing cyclocarya paliurus total flavonoid with effect of reducing blood glucose Pending CN104013669A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410293019.XA CN104013669A (en) 2014-06-24 2014-06-24 Method for preparing cyclocarya paliurus total flavonoid with effect of reducing blood glucose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410293019.XA CN104013669A (en) 2014-06-24 2014-06-24 Method for preparing cyclocarya paliurus total flavonoid with effect of reducing blood glucose

Publications (1)

Publication Number Publication Date
CN104013669A true CN104013669A (en) 2014-09-03

Family

ID=51430852

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410293019.XA Pending CN104013669A (en) 2014-06-24 2014-06-24 Method for preparing cyclocarya paliurus total flavonoid with effect of reducing blood glucose

Country Status (1)

Country Link
CN (1) CN104013669A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104305173A (en) * 2014-09-25 2015-01-28 南京中医药大学 Health food for diabetics and preparation method thereof
CN104940282A (en) * 2015-06-05 2015-09-30 百花医花集团股份有限公司 Cyclocarya paliurus preparation and preparation method thereof
CN112106910A (en) * 2020-08-05 2020-12-22 宁波大学 Soda water health beverage containing cyclocarya paliurus flavone and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
杨武英等: "青钱柳黄酮对α-葡萄糖苷酶活性及小鼠血糖的影响", 《营养学报》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104305173A (en) * 2014-09-25 2015-01-28 南京中医药大学 Health food for diabetics and preparation method thereof
CN104940282A (en) * 2015-06-05 2015-09-30 百花医花集团股份有限公司 Cyclocarya paliurus preparation and preparation method thereof
CN112106910A (en) * 2020-08-05 2020-12-22 宁波大学 Soda water health beverage containing cyclocarya paliurus flavone and preparation method thereof

Similar Documents

Publication Publication Date Title
CN102274244B (en) Cassia bark polyphenol extract and preparation method and application thereof
CN101632827B (en) Traditional Chinese medicine composition for treating psoriasis and preparation method thereof
CN103070880B (en) Application of acanthopanax trifoliatus polysaccharide in preparing medicine for treating diabetes
CN101264122A (en) Hypericum extract, its preparation method, its pharmaceutical composition and its application in treating diabetes
CN103479963A (en) Traditional Chinese medicine capsules for treating rheumatoid arthritis and preparation method thereof
CN105687441A (en) Application of litchi rind polyphenol in medicines for treating hyperglycemia and insulin resistance
CN104922173A (en) Application of radix acanthopanacis trifoliate extract in inhibiting alpha-glucosidase
CN104840527A (en) Composition containing tenuifoliside and ginsenoside
CN104013669A (en) Method for preparing cyclocarya paliurus total flavonoid with effect of reducing blood glucose
CN105267559A (en) Diabetic peripheral neuropathy treatment medicine and manufacturing method thereof
CN102793798B (en) Medicinal composition for auxiliary treatment of diabetic coronary artery disease
CN102293796A (en) Active part of lysimachia trientaloides Hemsl., and extraction method and application of active part
CN112741862A (en) Compound medicine of coptis, astragalus, notoginseng and rehmannia for preventing and treating diabetes and its complication
CN105267564A (en) Application of total saponin of Dioscorea in preparation of drugs for controlling diabetic nephropathy
CN105169187B (en) A kind of composition and its application, preparation method and drug, food containing the composition
CN105168300A (en) Pharmaceutical composition for treating diabetes and preparation method thereof
CN102727624B (en) New application of enteritis peaching composition on treatment of chronic prostatitis
CN114712475B (en) Dai medicine composition for preventing and/or treating reperfusion injury after myocardial ischemia and preparation method and application thereof
CN108743885A (en) A kind of Chinese medicine and preparation method thereof for treating Diabetic Macrovascular Complications
CN101564409B (en) Application of traditional Chinese indian lettuce in preparation of diabetes drugs
CN109939176B (en) A kind of pharmaceutical composition for treating diabetes and preparation method thereof
CN105287865A (en) Medicinal composition for treating malignant tumor
CN101385768A (en) Extract from the root of sheep roe japonicus and its preparation method and its application in the preparation of medicine for treating chronic glomerulonephritis
CN107213204B (en) A kind of traditional Chinese medicine compound preparation for treating diabetes and its preparation method and application
CN107325071A (en) A kind of preparation method and purposes of the Hickory Leaves pinostrobin with hypoglycemic effect

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140903